Growth Metrics

LeonaBio (LONA) Operating Leases (2020 - 2026)

LeonaBio (LONA) reported Operating Leases of $213000.0 for Q1 2026, down 69.18% year-over-year from $691000.0 in Q1 2025, and down 36.98% on a QoQ basis from $338000.0 in Q4 2025.

LeonaBio (LONA) has 7 years of Operating Leases data on file, last reported at $213000.0 in Q1 2026.

  • Quarterly Operating Leases fell 69.18% year-over-year to $213000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $213000.0 (down 69.18% YoY) and the FY2025 annual result came in at $338000.0, down 57.91% from the prior year.
  • Operating Leases eased to $213000.0 in Q1 2026 per LONA's latest filing, from $338000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.8 million in Q2 2022 and bottomed at $213000.0 in Q1 2026.
  • The 5-year median for Operating Leases is $1.1 million (2024), against an average of $1.1 million.
  • The widest annual swing landed in 2022, when Operating Leases fell 1.52%; it then sank 69.18% in 2026.
  • Tracing LONA's Operating Leases over 5 years: stood at $1.6 million in 2022, then slipped by 23.22% to $1.2 million in 2023, then tumbled by 34.02% to $803000.0 in 2024, then plunged by 57.91% to $338000.0 in 2025, then plunged by 36.98% to $213000.0 in 2026.
  • Per Business Quant, the three latest LONA Operating Leases figures stand at $213000.0 (Q1 2026), $338000.0 (Q4 2025), and $460000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 LeonaBio 181.52 Mn 113.84 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 213,000.00
Dec 31, 2025 338,000.00
Sep 30, 2025 460,000.00
Jun 30, 2025 578,000.00
Mar 31, 2025 691,000.00
Dec 31, 2024 803,000.00
Sep 30, 2024 912,000.00
Jun 30, 2024 1.02 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 1.31 Mn
Jun 30, 2023 1.41 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 1.67 Mn
Jun 30, 2022 1.75 Mn
Mar 31, 2022 1.55 Mn
Dec 31, 2021 1.63 Mn
Sep 30, 2021 1.71 Mn
Jun 30, 2021 1.78 Mn
Mar 31, 2021 1.70 Mn
Dec 31, 2020 876,000.00
Sep 30, 2020 915,000.00